Fluorescent in situ hybridization with a panel of probes detects molecular cytogenetic abnormalities in patients with chronic lymphocytic leukemia

National Medical Journal of China

Volumn 88, Issue 36, 2008, Pages 2537-2540

  Xu, Wei ^a   Li, Jian Yong ^a   Li, Li ^a   Yu, Hui ^a   Shen, Qiu Dan ^a   Fan, Lei ^a   Qiao, Chun ^a   Hong, Ming ^a   Qian, Si Xuan ^a   Qiu, Hong Xia ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Fluorescence in situ hybridization; Leukemia, lymphocytic, chronic

Indexed keywords

ATM PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN H; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CHINESE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; INTERPHASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MOLECULAR PROBE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SURVIVAL TIME; TRISOMY 12;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NUCLEIC ACID PROBES; SURVIVAL RATE;

EID: 56849131822     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Xu W, Li JY, Pan JL, et al. Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in Chinese patients with B-cell chronic lymphocytic leukemia. Int J Hematol, 2007,85:430-436.
2. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 1981, 48:198-206.
3. Xu W, Li JY, Wu YJ, et al. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. Leuk Res, 2008,32:1071-1077.
4. Dohner H, Stilgenhauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med, 2000, 343: 1910-1916.
5. Mayr C, Speicher MR, Kofler DM, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood, 2005, 105: 2093-2123.
6. Thornton PD, Gruszka-Westwood AM, Hamoudi RA, et al. Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. Hematol J, 2004, 5: 47-54.
7. Stilgenbauer S, Dohner H. Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am, 2004, 18: 827-848.
8. Doneda L, Montillo M, Intropido L, et al. Interphase fluorescence in situ hybridization analysis of del(11) (q23) and del(17) (p13) in chronic lymphocytic leukemia: a study of 40 early-onset patients. Cancer Genet Cytogenet, 2003,140:31-36.
9. Reddy KS. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol, 2006,132:705-722.
10. Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet, 2005, 158: 88-91.
11. Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin Oncol, 1998,25:19-26.
12. Geisler CH, Philip P, Christensen BE, et al. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res, 1997, 21: 1011-1023.
13. Cuneo A, Rigolin GM, Bigoni R, et al. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Leukemia, 2004, 18: 476-483.